SFJ Pharmaceuticals, Inc.
Tim Stillwell has extensive experience in program management and clinical trial project management within the pharmaceutical industry, holding various leadership positions since 2012. At SFJ Pharmaceuticals, Inc., Tim served as Senior Director for nearly three years, leading cross-functional coordination and problem-solving efforts. Prior roles at Eli Lilly and Company included Associate Director and Senior Clinical Trial Project Manager in Oncology, contributing to project management and coordination. Earlier experience includes positions at Gilead Sciences and Covance, focusing on clinical trial management and global study management. Tim's educational background includes a Bachelor of Science in Biochemistry from the University of New Hampshire and a Biochemistry Major from Indiana Wesleyan University.
This person is not in any teams
This person is not in any offices
SFJ Pharmaceuticals, Inc.
The SFJ Pharmaceuticals Group ® mission is to accelerate the availability of new and innovative drugs into the world’s major markets, by providing not only additional funding, but also strategic development expertise to enable our Pharma and Biotech partners to be as hands off or as hands on as they wish. Currently there is significant downwardpressure on drug development resources. In the case of large Pharma the so called “patent cliff” has hit hard leaving no company unaffected. This leads to dramatic R+D budget cuts. For Biotech there is a chronic lack of external funding available. The SFJ Pharmaceuticals Group ® mission is to enable these companies to continue to develop their most important drug candidates without increasing the burden on their P&L or cash reserves. SFJ will take 100% of the clinical and regulatory risk.